This randomized phase III trial studies bortezomib, lenalidomide, and dexamethasone to see how well they work compared to carfil

Skip to Content

Clinical Trial Details

Bortezomib or Carfilzomib with Lenalidomide and Dexamethasone in Treating Multiple Myeloma Patients

This randomized phase III trial studies bortezomib, lenalidomide, and dexamethasone to see how well they work compared to carfilzomib, lenalidomide, and dexamethasone in treating patients with newly diagnosed multiple myeloma.

Objective

Visit the National Cancer Institute's Web Site.

IRB Protocol Number
ECOG-ACRIN E1A11

Clinical Trial Categories

  • Myeloma
Contact
NH Oncology Hematology Clinical Research Dept. at 603-224-2556

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000